Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema

Contact Dermatitis
Dana BoehmKristine Breuer

Abstract

Occupational hand eczema is one of the most frequent occupational diseases. Few data about the prevalence of mental comorbidities are available. Objectives. We aimed to investigate the prevalence of anxiety, depression symptoms, the impairment of health-related quality of life (HRQoL) and their correlates in patients with occupational hand eczema. A test battery consisting of the German versions of the Hospital Anxiety and Depression Scale, the Dermatology Life Quality Index (DLQI) as a specific instrument and the Short Form Health Survey-36 (SF-36) as a generic instrument for HRQoL was applied in 122 patients. The severity of hand eczema was assessed with the Osnabrueck Hand Eczema Severity Index (OHSI). Twenty per cent of patients had a positive anxiety score, and 14% had a positive depression score. Higher anxiety levels, a greater impairment in the SF-36 mental component summary score and a higher DLQI category score for symptoms and feelings was detected in females than in males. The OHSI correlated with the impairment in HRQoL, and an association of severe hand eczema with symptoms of anxiety and depression was found in males. We found a high prevalence of anxiety and depression in our study population of patients with oc...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
May 8, 1999·The British Journal of Dermatology·J Linnet, G B Jemec
Feb 24, 2001·Journal of Occupational and Environmental Medicine·G E SimonR C Kessler
Jun 26, 2001·Contact Dermatitis·C V HutchingsD J Gawkrodger
Feb 8, 2002·Journal of Psychosomatic Research·Ingvar BjellandDag Neckelmann
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P E SchofieldS M Dunn
Apr 12, 2003·International Archives of Occupational and Environmental Health·Thomas L Diepgen
Jun 4, 2004·The Journal of Investigative Dermatology·Lena-Marie WallenhammarBirgitta Meding
Sep 28, 2005·The Journal of Investigative Dermatology·Yan HongboAndrew Y Finlay
Feb 21, 2006·Contact Dermatitis·Rikke Skoet CvetkovskiTove Agner
Feb 2, 2008·International Archives of Occupational and Environmental Health·C SkudlikS M John
Sep 2, 2008·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christoph SkudlikSwen Malte John
Mar 24, 2009·The British Journal of Dermatology·C MobergB Meding
Sep 29, 2009·Contact Dermatitis·Uwe MatterneElke Weisshaar
Aug 19, 2010·The British Journal of Dermatology·T MälkönenP Susitaival
May 14, 2011·The British Journal of Dermatology·I Anveden BerglindB Meding
Jun 21, 2011·The Journal of Allergy and Clinical Immunology·Marcia J SlatteryJames E Gern
Jun 28, 2011·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·L KovacsN A Papadopulos

❮ Previous
Next ❯

Citations

Jul 17, 2013·Dermatitis : Contact, Atopic, Occupational, Drug·Massimo GolaLuca Marmugi
Jul 6, 2014·Occupational Medicine·D BöhmK Breuer
Jan 18, 2013·Current Opinion in Allergy and Clinical Immunology·Dorothy Linn Holness
Mar 4, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·K BreuerG Schmid-Ott
Jan 24, 2014·Contact Dermatitis·Maria V HeisterbergJeanne D Johansen
Sep 23, 2014·The British Journal of Dermatology·J I Silverberg
May 23, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Manigé FartaschSibylle Schliemann
Feb 5, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·K BreuerG Schmid-Ott
Feb 20, 2015·Contact Dermatitis·Anargyros KourisGeorgios Kontochristopoulos
May 26, 2015·Actas dermo-sifiliográficas·F J de LeónJ F Silvestre
May 25, 2016·Contact Dermatitis·Klaziena PolitiekMarie-Louise A Schuttelaar
Dec 20, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinAnja Kamps
Dec 20, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinAnja Kamps
Jun 24, 2014·Annales de dermatologie et de vénéréologie·B Halioua
Jun 24, 2014·Annales de dermatologie et de vénéréologie·P GelotUNKNOWN Avec soutien du Groupe d’Éducation Thérapeutique de Société Française de Dermatologie
Feb 22, 2018·Contact Dermatitis·Servando E MarronPedro C Marijuan
Jan 9, 2018·Journal of Cutaneous Medicine and Surgery·Erika L CrowleyMelinda J Gooderham
Jul 20, 2016·Dermatitis : Contact, Atopic, Occupational, Drug·Jacquelyn Swietlik, Margo Reeder
May 2, 2020·Contact Dermatitis·Annarita AntelmiCecilia Svedman
Jul 29, 2019·Current Allergy and Asthma Reports·Dorothy Linn Holness
Feb 27, 2020·Contact Dermatitis·Valerie AndreesUNKNOWN ROQ-Study group
Feb 26, 2020·Psychiatry Investigation·Paraskevi MavrogiorgouGeorg Juckel
Aug 14, 2019·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·R F Ofenloch, E Weisshaar
May 1, 2018·The Cochrane Database of Systematic Reviews·Andrea BauerHywel C Williams
Nov 17, 2020·Dermatitis : Contact, Atopic, Occupational, Drug·Lindsey M VollerSara A Hylwa
Jan 29, 2018·Neuroscience and Biobehavioral Reviews·Kristen M Sanders, Tasuku Akiyama
May 29, 2021·Nature Reviews. Disease Primers·Pamela L ScheinmanAri M Goldminz
Jul 7, 2021·Immunology and Allergy Clinics of North America·Dorothy Linn Holness
Apr 30, 2021·Italian Journal of Dermatology and Venereology·Serap MadenSebnem Aktan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.